TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 50.00
+0.30 (0.60%)
Aug 19, 2026, 1:30 PM CST
TSH Biopharm Corporation Market Cap
TSH Biopharm Corporation has a market cap or net worth of 1.91 billion as of August 19, 2026. Its market cap has increased by 3.87% in one year.
Market Cap
1.91B
Enterprise Value
1.12B
Revenue
1.40B
Ranking
n/a
PE Ratio
11.43
Stock Price
50.00
ChartMarket Cap Chart
Since June 16, 2011, TSH Biopharm Corporation's market cap has decreased from 1.96B to 1.91B, a decrease of -2.74%. That is a compound annual growth rate of -0.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 1.92B | -14.53% |
| Dec 31, 2025 | 2.25B | -4.57% |
| Dec 31, 2024 | 2.35B | 21.87% |
| Dec 29, 2023 | 1.93B | 5.78% |
| Dec 30, 2022 | 1.83B | 6.85% |
| Dec 30, 2021 | 1.71B | -24.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yoda Pharmaceuticals | 3.57B |
| Maywufa Company | 2.78B |
| Merdury Biopharmaceutical | 2.54B |
| Johnson Chemical Pharmaceutical Works | 2.48B |
| Allied Biotech | 2.29B |
| PhytoHealth | 2.23B |
| GeneFerm Biotechnology | 1.27B |
| InnoPharmax | 1.23B |